Rubicon Research P/E Ratio

RUBICON • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
63.1
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 63.1
Current Price ₹774.85
EPS (TTM) ₹8.82
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 45.78
Historical Range 45.78 - 45.78
Percentile 100.0%

Sector Context

Sector Average 47.04
Sector Median 25.62
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹13.11
Sept 2025 ₹3.49
Mar 2025 ₹2.35

Key P/E Ratio Insights for Rubicon Research

  • Stock appears overvalued with PE of 63.1, suggesting caution for new investments
  • Current PE is 37.8% above historical average
  • Trading at premium to sector average PE of 47.04

P/E Ratio Historical Trend for Rubicon Research

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 45.78 13.11 ₹600.15 NSE High

Sector P/E Ratio Comparison

Comparing Rubicon Research with other companies in Healthcare sector
Sector Average
47.04
Sector Median
25.62
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low